Cargando…

Platelet Rich Plasma in Androgenic Alopecia: Where do we Stand?

Detalles Bibliográficos
Autor principal:	Godse, Kiran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134642/ https://www.ncbi.nlm.nih.gov/pubmed/25136213

Ejemplares similares

Efficacy of platelet-rich plasma in treatment of androgenic alopecia
por: Singhal, Parul, et al.
Publicado: (2015)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Platelet-Rich Plasma in Androgenic Alopecia: Myth or an Effective Tool
por: Khatu, Swapna S, et al.
Publicado: (2014)

Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013)

Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Surgical trials in India, where do we stand?
por: Khajanchi, M
Publicado: (2022)

Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?
por: Mu, Jun, et al.
Publicado: (2011)

Immunosenescence and Cytomegalovirus: where do we stand after a decade?
por: Pawelec, Graham, et al.
Publicado: (2010)

Commentary: Deep learning in retinopathy of prematurity: Where do we stand?
por: Sen, Parveen, et al.
Publicado: (2022)

Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?
por: Alexandre, Maria Inês, et al.
Publicado: (2023)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Calcium and Vitamin D in the Regulation of Energy Balance: Where Do We Stand?
por: Soares, Mario J., et al.
Publicado: (2014)

Effectiveness of Platelet-Rich Plasma Therapy in Androgenic Alopecia—A Meta-Analysis
por: Georgescu, Simona Roxana, et al.
Publicado: (2022)

Risk stratification tools in prostate cancer, where do we stand?
por: Clinckaert, Andries, et al.
Publicado: (2021)

Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
por: Miller, Kathy D
Publicado: (2004)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Commentary: Viral serology testing before cataract surgery: Where do we stand?
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Platelet-rich Plasma by Single-spin Process in Male Pattern Androgenetic Alopecia: Is it an Effective Treatment?
por: Arshdeep,
Publicado: (2017)

Where Do We Stand?
Publicado: (1891)

Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand?
por: Lagiou, Pagona
Publicado: (2006)

Commentary: Systemic versus imaging biomarkers for diabetic macular oedema – Where do we stand?
por: Rana, Vipin, et al.
Publicado: (2021)

Platelet-Rich Plasma in Androgenetic Alopecia
por: Sharma, Aseem, et al.
Publicado: (2021)

Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
por: Choi, Jonggi, et al.
Publicado: (2016)

Platelet-Rich Plasma in Female Androgenic Alopecia: A Comprehensive Systematic Review and Meta-Analysis
por: Zhou, Shuying, et al.
Publicado: (2021)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Sperm DNA fragmentation testing: where we stand in 2017
por: Tandon, Salil
Publicado: (2017)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

The hazards and risks of inhaled poorly soluble particles – where do we stand after 30 years of research?
por: Borm, Paul J. A., et al.
Publicado: (2019)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Platelet-Rich Plasma Therapy for Androgenetic Alopecia
por: Sharma, Vinod K, et al.
Publicado: (2019)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
por: Godoy, Lucas C, et al.
Publicado: (2019)

Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?
por: Azfr Ali, Ruba Saleh, et al.
Publicado: (2021)

Is There Sufficient Research Data to Use Platelet-Rich Plasma in Dermatology?
por: Marwah, Manjot, et al.
Publicado: (2014)

Genetics of Keratoconus: Where Do We Stand?
por: Abu-Amero, Khaled K., et al.
Publicado: (2014)

Cricoid pressure: Where do we stand?
por: Bhatia, Nidhi, et al.
Publicado: (2014)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qd3js1sg51kihr2e0lk1r8e8p